We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Moberg Pharma Ab (publ) | LSE:0P48 | London | Ordinary Share | SE0003613090 | MOBERG PHARMA ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 30.45 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
STOCKHOLM, Oct. 18, 2019 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) implements changes in the management team where Mark Beveridge, VP Finance, reassumes responsibility for the finance function and replaces Sarah Hellerfelt who has decided to leave her position as CFO for the company.
Mark Beveridge is a chartered accountant and joined Moberg Pharma in 2015, previously having served as senior advisor to the company in accounting and ERP systems. As Vice President Finance, he is a key member of Moberg's transaction and finance team. Mark brings extensive experience within system and financial management with a strong background in accounting, audit and advisory services.
"I look forward to continue working together with Mark Beveridge. I would also like to thank Sarah Hellerfelt for her excellent contributions to the company over the past years and wish her all the best in the future", says Anna Ljung, CEO of Moberg Pharma.
CONTACT:
For additional information, please contact:
Anna Ljung, CEO, telephone: +46 707 66 60 30, E-mail: anna.ljung@mobergpharma.se
Mark Beveridge, Vice President Finance, telephone: +46 8 522 307 00, e-mail: mark.beveridge@mobergpharma.se
About this information
The information was submitted for publication, through the agency of the contact persons set out above, at 4.00 p.m. CET on October 18th, 2019.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/moberg-pharma/r/changes-to-moberg-pharma-s-management-team,c2935508
The following files are available for download:
https://mb.cision.com/Main/1662/2935508/1125497.pdf | Changes to Moberg Pharma´s management team |
View original content:http://www.prnewswire.com/news-releases/changes-to-moberg-pharmas-management-team-300941245.html
SOURCE Moberg Pharma
Copyright 2019 PR Newswire
1 Year Moberg Pharma Ab (publ) Chart |
1 Month Moberg Pharma Ab (publ) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
